Documents
Application Sponsors
ANDA 211827 | TEVA PHARMS USA | |
Marketing Status
None (Tentative Approval) | 001 |
Application Products
001 | SOLUTION;TOPICAL | 10% | 0 | EFINACONAZOLE | EFINACONAZOLE |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2019-10-16 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
TEVA PHARMS USA
cder:Array
(
[0] => Array
(
[ApplNo] => 211827
[companyName] => TEVA PHARMS USA
[docInserts] => ["",""]
[products] => [{"drugName":"EFINACONAZOLE","activeIngredients":"EFINACONAZOLE","strength":"10%","dosageForm":"SOLUTION;TOPICAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"10\/16\/2019","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/211827Orig1s000TAltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-10-16
)
)